Association and interaction analysis of excess weight and chronic kidney disease for cardiovascular autonomic neuropathy in the general Chinese population

Reference

• Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–1209
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–781
   PubMed Web of Science ®Google Scholar
• Tahrani AA, Dubb K, Raymond NT, et al. Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: A cohort study. Diabetologia. 2014;57:1249–1256
   PubMed Web of Science ®Google Scholar
• Smulders YM, Jager A, Gerritsen J, et al. Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian sujects with impaired glucose tolerance or type 2 diabetes: The Hoorn Study. Diabetes Care. 2000;23:1369–1374
   PubMed Web of Science ®Google Scholar
• Hazari MA, Khan RT, Reddy BR, Hassan M. Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences. 2012;17:173–175
   Web of Science ®Google Scholar
• Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes/Metab Res Rev. 2011;27:639--653
   PubMed Web of Science ®Google Scholar
• Garruti G, Giampetruzzi F, Vita MG, et al. Links between metabolic syndrome and cardiovascular autonomic dysfunction. Exp Diabetes Res. 2012;2012:615835
   PubMed Web of Science ®Google Scholar
• Iodice V, Low DA, Vichayanrat E, Mathias CJ. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: Similarities and differences. J Neurol Sci. 2011;310:133–138
   PubMed Web of Science ®Google Scholar
• Laitinen T, Lindstrom J, Eriksson J, et al. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabetic Med. 2011;28:699–704
   PubMed Web of Science ®Google Scholar
• dos Reis Santos I, Danaga AR, de Carvalho Aguiar I, et al. Cardiovascular risk and mortality in end-stage renal disease patients undergoing dialysis: Sleep study, pulmonary function, respiratory mechanics, upper airway collapsibility, autonomic nervous activity, depression, anxiety, stress and quality of life: A prospective, double blind, randomized controlled clinical trial. BMC Nephrol. 2013;14:215
   PubMed Web of Science ®Google Scholar
• Li Z, Tang ZH, Zeng F, Zhou L. Associations between the severity of metabolic syndrome and cardiovascular autonomic function in a Chinese population. J Endocrinol Invest. 2013;36:993–999
   PubMed Web of Science ®Google Scholar
• Lu Y, Tang ZH, Zeng F, Li Y, Zhou L. The association and predictive value analysis of metabolic syndrome combined with resting heart rate on cardiovascular autonomic neuropathy in the general Chinese population. Diabetology Metabolic Syndrome. 2013;5:73--80
   PubMedGoogle Scholar
• Astrup AS, Tarnow L, Rossing P, et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2006;29:334–339
   PubMed Web of Science ®Google Scholar
• Assoumou HG, Pichot V, Barthelemy JC, et al. Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: The PROOF study. Rejuvenation Res. 2010;13:653–663
   PubMed Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
   PubMed Web of Science ®Google Scholar
• Schabath MB, Spitz MR, Delclos GL, et al. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Industrial Med. 2002;42:29–37
   PubMed Web of Science ®Google Scholar
• Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–579
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467–470
   PubMed Web of Science ®Google Scholar
• Hallqvist J, Ahlbom A, Diderichsen F, Reuterwall C. How to evaluate interaction between causes: A review of practices in cardiovascular epidemiology. J Intern Med. 1996;239:377–382
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ, Robins JM. The identification of synergism in the sufficient-component-cause framework. Epidemiology. 2007;18:329–339
   PubMed Web of Science ®Google Scholar
• Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286–290
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Inter Med. 1999;130:461–470
   Google Scholar
• Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109:551–556
   PubMed Web of Science ®Google Scholar
• Zeng F, Tang ZH, Li Z, Yu X, Zhou L. Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people. J Endocrinol Invest. 2014;37:385--391
   PubMed Web of Science ®Google Scholar
• Tang ZH, Zeng F, Yu X, Zhou L. Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on baroreflex sensitivity in the absence of a gold standard. Int J Cardiol. 2014;171:e78–e80
   Web of Science ®Google Scholar
• Bian RW, Lou QL, Gu LB, et al. Delayed gastric emptying is related to cardiovascular autonomic neuropathy in Chinese patients with type 2 diabetes. Acta Gastroenterol Belg. 2011;74:28–33
   PubMed Web of Science ®Google Scholar
• Ding W, Zhou L, Bao Y, et al. Autonomic nervous function and baroreflex sensitivity in hypertensive diabetic patients. Acta Cardiol. 2011;66:465–470
   PubMed Web of Science ®Google Scholar
• Lee K, Park J, Choi J, Park CG. Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia. J Korean Acad Nurs. 2011;41:788–794
   PubMed Web of Science ®Google Scholar
• Chang YW, Lin JD, Chen WL, et al. Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities. Res Dev Disabil. 2012;33:1701–1707
   PubMed Web of Science ®Google Scholar
• Jarczok MN, Li J, Mauss D, Fischer JE, Thayer JF. Heart rate variability is associated with glycemic status after controlling for components of the metabolic syndrome. Int J Cardiol. 2013;167:855--861
   PubMed Web of Science ®Google Scholar
• Lucini D, de Giacomi G, Tosi F, et al. Altered cardiovascular autonomic regulation in overweight children engaged in regular physical activity. Heart. 2013;99:376–381
   PubMed Web of Science ®Google Scholar
• Lambert E, Sari CI, Dawood T, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010;56:351–358
   PubMed Web of Science ®Google Scholar
• Krishnan AV, Kiernan MC. Uremic neuropathy: Clinical features and new pathophysiological insights. Muscle Nerve. 2007;35:273–290
   PubMed Web of Science ®Google Scholar
• Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Sem Nephrol. 2013;33:54–65
   PubMed Web of Science ®Google Scholar
• Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012;8:405–416
   PubMed Web of Science ®Google Scholar
• Salman IM, Ameer OZ, Sattar MA, et al. Renal sympathetic nervous system hyperactivity in early streptozotocin-induced diabetic kidney disease. Neurourol Urodyn. 2011;30:438–446
   PubMed Web of Science ®Google Scholar